5PSQ-034 Assessment of linezolid’s haemotological toxicity and related risk factors in clinical practice

BACKGROUND: Linezolid is an antibiotic used for several infections, such as community acquired pneumonia, nosocomial pneumonia and skin and soft tissue infections. Its use has increased over the past years, raising concerns about the incidence in clinical practice of haematological toxicity (HT) rel...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Hosp Pharm
Autors principals: del Río, J Marco, Martínez, EM García, Walsh, A Valladolid, Rubio, F Sánchez, Alpuente, I Pérez, Sánchez, S Ruiz, Candel, G Romero
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2018
Matèries:
Section 5: Patient safety and quality assurance
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535297/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.388
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars